ANI PHARMACEUTICALS, INC Total Assets
ANI PHARMACEUTICALS, INC (ANIP) had Total Assets of $1.49 billion as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-07
- 2026-06-30: Assets $1.49B.
- 2026-03-31: Assets $1.42B.
- 2025-12-31: Assets $1.44B.
- 2025-09-30: Assets $1.41B.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $1.49B 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $1.42B 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $1.44B 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $1.41B 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $1.34B 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $1.29B 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $1.28B 10-K · filed 2026-02-27 | $1.28B 10-K · filed 2025-02-28 |
| 2024-09-30 | $1.29B 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $920.75M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $914.52M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $904.42M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $889.91M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $859.34M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $765.22M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $760.09M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $739.11M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $751.33M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $744.85M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $771.60M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $470.45M 10-Q · filed 2021-11-01 | |
| 2021-06-30 | $480.16M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $463.84M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $461.19M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $462.58M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $465.39M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $482.23M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $456.79M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $456.77M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $446.91M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $434.39M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $430.60M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $439.44M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $424.18M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $418.02M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $412.14M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $370.47M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $359.22M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $357.14M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $322.86M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $319.38M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $308.00M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $291.59M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $285.26M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $283.28M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $270.12M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $265.99M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $259.56M 10-K · filed 2016-02-23 | $263.71M 10-K · filed 2015-02-23 |
| 2014-09-30 | $107.64M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $95.42M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $96.65M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $44.50M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $43.29M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $41.66M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $35.36M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $13.75M 10-K · filed 2014-02-28 | $38.77M 10-K · filed 2013-02-28 |
| 2012-09-30 | $43.21M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $47.29M 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $54.57M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $62.38M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $74.89M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $42.76M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $44.77M 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |